IRIS Accounts Production v23.3.1.45 09590838 director 1.6.22 31.5.23 31.5.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095908382022-05-31095908382023-05-31095908382022-06-012023-05-31095908382021-05-31095908382021-06-012022-05-31095908382022-05-3109590838ns10:Originalns15:EnglandWales2022-06-012023-05-3109590838ns14:PoundSterlingns10:Original2022-06-012023-05-3109590838ns10:Originalns10:Director12022-06-012023-05-3109590838ns10:Original2022-06-012023-05-3109590838ns10:Original2023-05-3109590838ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3109590838ns10:Originalns10:SmallEntities2022-06-012023-05-3109590838ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3109590838ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3109590838ns10:Originalns10:FullAccounts2022-06-012023-05-3109590838ns10:Originalns10:RegisteredOffice2022-06-012023-05-3109590838ns10:Original2022-05-3109590838ns10:Originalns5:CurrentFinancialInstruments2023-05-3109590838ns10:Originalns5:CurrentFinancialInstruments2022-05-3109590838ns5:ShareCapitalns10:Original2023-05-3109590838ns5:ShareCapitalns10:Original2022-05-3109590838ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3109590838ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3109590838ns10:Originalns5:PlantMachinery2022-06-012023-05-3109590838ns10:Original2021-06-012022-05-3109590838ns10:Originalns5:PlantMachinery2022-05-3109590838ns10:Originalns5:PlantMachinery2023-05-3109590838ns10:Originalns5:PlantMachinery2022-05-3109590838ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3109590838ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-31
REGISTERED NUMBER: 09590838 (England and Wales)














SABITA ANAESTHETICS LTD

Unaudited Financial Statements

for the Year Ended 31 May 2023






SABITA ANAESTHETICS LTD (REGISTERED NUMBER: 09590838)

Contents of the Financial Statements
for the Year Ended 31 May 2023










Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6


SABITA ANAESTHETICS LTD

Company Information
for the Year Ended 31 May 2023







Director: Dr S Sreevalsan





Registered office: Artisans' House
7 Queensbridge
Northampton
Northamptonshire
NN4 7BF





Registered number: 09590838 (England and Wales)





Accountants: Cobley Desborough
Chartered Certified Accountants
Chartered Tax Advisers
Artisans' House
7 Queensbridge
Northampton
Northamptonshire
NN4 7BF

SABITA ANAESTHETICS LTD (REGISTERED NUMBER: 09590838)

Balance Sheet
31 May 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 952 1,120

CURRENT ASSETS
Debtors 5 4,340 3,730
Cash at bank 130,642 112,236
134,982 115,966
CREDITORS
Amounts falling due within one year 6 10,309 11,851
NET CURRENT ASSETS 124,673 104,115
TOTAL ASSETS LESS CURRENT
LIABILITIES

125,625

105,235

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 125,525 105,135
SHAREHOLDERS' FUNDS 125,625 105,235

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SABITA ANAESTHETICS LTD (REGISTERED NUMBER: 09590838)

Balance Sheet - continued
31 May 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 February 2024 and were signed by:





Dr S Sreevalsan - Director


SABITA ANAESTHETICS LTD (REGISTERED NUMBER: 09590838)

Notes to the Financial Statements
for the Year Ended 31 May 2023


1. STATUTORY INFORMATION

Sabita Anaesthetics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 15% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

SABITA ANAESTHETICS LTD (REGISTERED NUMBER: 09590838)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


2. ACCOUNTING POLICIES - continued

Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Going concern
The current economic conditions present increased risks for all businesses. In response to such conditions, the director has carefully considered these risks, including an assessment of uncertainty on future trading projections for a period of at least twelve months from the date of signing the financial statements, and the extent to which they might affect the preparation of the financial statements on a going concern basis.

Based on this assessment, the director considers that the Company maintains an appropriate level of liquidity, sufficient to meet the demands of the business including any capital and servicing obligations of external liabilities.

In addition, the Company's assets are assessed for recoverability on a regular basis, and the director considers that the Company is not exposed to losses of these assets which would affect their decision to adopt the going concern basis.

The director is therefore satisfied and has a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and that there are no material uncertainties that lead to significant doubt upon the Company's ability to continue as a going concern. Theses financial statements have therefore been prepared on a going concern basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

SABITA ANAESTHETICS LTD (REGISTERED NUMBER: 09590838)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
Cost
At 1 June 2022
and 31 May 2023 2,611
Depreciation
At 1 June 2022 1,491
Charge for year 168
At 31 May 2023 1,659
Net book value
At 31 May 2023 952
At 31 May 2022 1,120

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 4,340 3,730

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 8,477 5,576
Other creditors 1,832 6,275
10,309 11,851